Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;173(5):636-640.
doi: 10.1007/s10517-022-05603-2. Epub 2022 Oct 10.

Effect of Glycodelin on the Cytokine Profile of Rats during Allogeneic Bone Marrow Cell Transplantation

Affiliations

Effect of Glycodelin on the Cytokine Profile of Rats during Allogeneic Bone Marrow Cell Transplantation

M S Bochkova et al. Bull Exp Biol Med. 2022 Sep.

Abstract

The protein glycodelin (PP14, PAEP) is associated with pregnancy and exhibits pronounced immunotropic properties. We studied the effect of glycodelin on the cytokine profile of blood serum during transplantation a suspension of allogeneic red bone marrow cells to Wistar rats. Recombinant glycodelin was administered to the animals 4 times (14 μg each time). Against the background of bone marrow cell transplantation, the levels of proinflammatory (IL-1α, IL-1β, and IL-18) and regulatory (IL-7, IL-12) cytokines and CSF (M-CSF) increased in blood serum, which indicates a systemic inflammatory response to the allograft. Glycodelin administration against the background of bone marrow cell allotransplantation led to a significant decrease in the proinflammatory cytokine IL-17A on day 21 of the experiment; the concentrations of the other cytokines remained unchanged. In general, glycodelin can suppress the level of IL-17A, a marker of graft rejection, which opens perspectives for its further investigation as a potential drug.

Keywords: Wistar rats; allogeneic transplant; cytokine profile; glycodelin.

PubMed Disclaimer

Similar articles

References

    1. Bochkova MS, Zamorina SA, Timganova VP, Khramtsov PV, Rayev MB. The role of glycodelin in the regulation of the immune system in the context of developing pregnancy. Med. Immunol. 2019;21(4):603-616. Russian. https://doi.org/10.15789/1563-0625-2019-4-603-616
    1. Alok A, Karande AA. The role of glycodelin as an immune-modulating agent at the feto-maternal interface. J. Reprod. Immunol. 2009;83(1-2):124-127. https://doi.org/10.1016/j.jri.2009.06.261 - DOI - PubMed
    1. Dixit A, Balakrishnan B, Karande AA. Immunomodulatory activity of glycodelin: implications in allograft rejection. Clin. Exp. Immunol. 2018;192(2):213-223. https://doi.org/10.1111/cei.13096 - DOI - PubMed - PMC
    1. Ogonek J, Kralj Juric M, Ghimire S, Varanasi PR, Holler E, Greinix H, Weissinger E. Immune reconstitution after allogeneic hematopoietic stem cell transplantation. Front. Immunol. 2016;7:507. https://doi.org/10.3389/fimmu.2016.00507 - DOI - PubMed - PMC
    1. Henden AS, Hill GR. Cytokines in graft-versus-host disease. J. Immunol. 2015;194(10):4604-4612. https://doi.org/10.4049/jimmunol.1500117 - DOI - PubMed

LinkOut - more resources